Commercial Contribution- Novel imaging biomarkers of t cell function to accelerate immunotherapies for pancreatic cancer

Project Details

StatusActive
Effective start/end date1/10/2131/10/25

Funding

  • Aquila Biomedical Limited: £10,000.00